Schecter Alison D. — SEC insider filings

SEC reporting owner CIK 1782448. 4 insider filings on record with FilingPulse; latest filed 2026-10-08.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2021-03-18 to 2026-10-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Axcella Health Inc. (AXLA)President - Research & Dev.3——3
Retension Pharmaceuticals, Inc. (RTSN)Chief Medical Officer1———

Insider filings — Schecter Alison D.

FiledFormIssuerReported transactionsSource
2026-10-083Retension Pharmaceuticals, Inc. (RTSN)Holdings only — no transactions reportedEDGAR
2022-02-104Axcella Health Inc. (AXLA)Grant/award (A): 56,000 (derivative) @ $0EDGAR
2021-12-144Axcella Health Inc. (AXLA)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2021-03-184Axcella Health Inc. (AXLA)Grant/award (A): 250,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-03-15 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1782448 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs